Perbak Capital Partners LLP Penumbra Inc Transaction History
Perbak Capital Partners LLP
- $568 Billion
- Q3 2025
A detailed history of Perbak Capital Partners LLP transactions in Penumbra Inc stock. As of the latest transaction made, Perbak Capital Partners LLP holds 3,773 shares of PEN stock, worth $1.05 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
3,773
Previous 1,496
152.21%
Holding current value
$1.05 Million
Previous $384 Million
148.95%
% of portfolio
0.17%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding PEN
# of Institutions
473Shares Held
30.6MCall Options Held
309KPut Options Held
95.9K-
Black Rock Inc. New York, NY4.26MShares$1.19 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.79MShares$500 Million0.05% of portfolio
-
State Street Corp Boston, MA1.16MShares$324 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il971KShares$270 Million0.04% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.6B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...